{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:17:33Z","timestamp":1794946653211,"version":"4.9.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"SI","license":[{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>As global vaccination campaigns against COVID-19 disease commence, vaccine safety needs to be closely assessed. The safety profile of mRNA-based vaccines in patients with autoimmune inflammatory rheumatic diseases (AIIRD) is unknown. The objective of this report is to raise awareness of reactivation of herpes zoster (HZ) following the BNT162b2 mRNA vaccination in patients with AIIRD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The safety of the BNT162b2 mRNA vaccination was assessed in an observational study monitoring post-vaccination adverse effects in patients with AIIRD (n\u2009=\u2009491) and controls (n\u2009=\u200999), conducted in two rheumatology departments in Israel.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of HZ was 1.2% (n\u2009=\u20096) in patients with AIIRD compared with none in controls. Six female patients aged 49\u2009\u00b1\u200911\u2009years with stable AIIRD: RA (n\u2009=\u20094), Sjogren\u2019s syndrome (n\u2009=\u20091), and undifferentiated connective disease (n\u2009=\u20091), developed the first in a lifetime event of HZ within a short time after the first vaccine dose in five cases and after the second vaccine dose in one case. In the majority of cases, HZ infection was mild, except a case of HZ ophthalmicus, without corneal involvement, in an RA patient treated with tofacitinib. There were no cases of disseminated HZ disease or postherpetic neuralgia. All but one patient received antiviral treatment with a resolution of HZ-related symptoms up to 6\u2009weeks. Five patients completed the second vaccine dose without other adverse effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Epidemiologic studies on the safety of the mRNA-based COVID-19 vaccines in patients with AIIRD are needed to clarify the association between the BNT162b2 mRNA vaccination and reactivation of zoster.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab345","type":"journal-article","created":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T11:49:38Z","timestamp":1618055378000},"page":"SI90-SI95","source":"Crossref","is-referenced-by-count":105,"title":["Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series"],"prefix":"10.1093","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5193-4207","authenticated-orcid":false,"given":"Victoria","family":"Furer","sequence":"first","affiliation":[{"name":"Rheumatology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devy","family":"Zisman","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Carmel Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Kibari","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Carmel Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2322","authenticated-orcid":false,"given":"Doron","family":"Rimar","sequence":"additional","affiliation":[{"name":"Rheumatology Unit, Bnei Zion Medical Center, Haifa, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2424-5865","authenticated-orcid":false,"given":"Yael","family":"Paran","sequence":"additional","affiliation":[{"name":"Infectious Diseases Departments, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ori","family":"Elkayam","sequence":"additional","affiliation":[{"name":"Rheumatology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,13]]},"reference":[{"key":"2021101018332647100_keab345-B1","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"2021101018332647100_keab345-B2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"2021101018332647100_keab345-B3","author":"Force"},{"key":"2021101018332647100_keab345-B4","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpesvirus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet"},{"key":"2021101018332647100_keab345-B5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1177\/2051013615599151","article-title":"Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective","volume":"3","author":"Johnson","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"2021101018332647100_keab345-B6","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2021101018332647100_keab345-B7","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.mayocp.2017.10.009","article-title":"Risk factors for herpes zoster: a systematic review and meta-analysis","volume":"92","author":"Kawai","year":"2017","journal-title":"Mayo Clin Proc"},{"key":"2021101018332647100_keab345-B8","doi-asserted-by":"crossref","first-page":"ofaa005","DOI":"10.1093\/ofid\/ofaa005","article-title":"Risk factors for herpes zoster infection: a meta-analysis","volume":"7","author":"Marra","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2021101018332647100_keab345-B9","doi-asserted-by":"crossref","first-page":"e001041","DOI":"10.1136\/rmdopen-2019-001041","article-title":"Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD","volume":"5","author":"Furer","year":"2019","journal-title":"RMD Open"},{"key":"2021101018332647100_keab345-B10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/acr.21928","article-title":"Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort study","volume":"65","author":"Veetil","year":"2013","journal-title":"Arthritis Care Res"},{"key":"2021101018332647100_keab345-B11","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1136\/annrheumdis-2016-209131","article-title":"Real-world comparative risks of herpes virus infections in tofacitinib and biologic-treated patients with rheumatoid arthritis","volume":"75","author":"Curtis","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2021101018332647100_keab345-B12","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","article-title":"A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology"},{"key":"2021101018332647100_keab345-B13","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients","volume":"83","author":"Marzano","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2021101018332647100_keab345-B14","doi-asserted-by":"crossref","first-page":"e13666","DOI":"10.1111\/dth.13666","article-title":"Herpes zoster might be an indicator for latent COVID 19 infection","volume":"33","author":"Elsaie","year":"2020","journal-title":"Dermatol Ther"},{"key":"2021101018332647100_keab345-B15","first-page":"318","article-title":"Herpes zoster may be a marker for COVID-19 infection during pregnancy","volume":"106","author":"Elsaie","year":"2020","journal-title":"Cutis"},{"key":"2021101018332647100_keab345-B16","doi-asserted-by":"crossref","first-page":"e13930","DOI":"10.1111\/dth.13930","article-title":"Herpes zoster as a potential complication of coronavirus disease 2019","volume":"33","author":"Pona","year":"2020","journal-title":"Dermatol Ther"},{"key":"2021101018332647100_keab345-B17","first-page":"e8998","article-title":"Herpes zoster co-infection in an immunocompetent patient with COVID-19","volume":"12","author":"Saati","year":"2020","journal-title":"Cureus"},{"key":"2021101018332647100_keab345-B18","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1111\/ene.14361","article-title":"Fellow of the American Academy of Neurology (FAAN). COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy","volume":"27","author":"Ferreira ACA de","year":"2020","journal-title":"Eur J Neurol"},{"key":"2021101018332647100_keab345-B19","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ijd.15001","article-title":"Herpes zoster in COVID-19-positive patients","volume":"59","author":"Tartari","year":"2020","journal-title":"Int J Dermatol"},{"key":"2021101018332647100_keab345-B20","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5811\/cpcem.2020.4.47557","article-title":"An unusual case report of COVID-19 presenting with meningitis symptoms and shingles","volume":"4","author":"Packwood","year":"2020","journal-title":"Clin Pract Cases Emerg Med"},{"key":"2021101018332647100_keab345-B21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jdcr.2020.05.012","article-title":"Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection","volume":"6","author":"Shors","year":"2020","journal-title":"JAAD Case Reports"},{"key":"2021101018332647100_keab345-B22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","article-title":"Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"2021101018332647100_keab345-B23","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.3389\/fimmu.2018.02569","article-title":"T-cell exhaustion in chronic infections: reversing the state of exhaustion and reinvigorating optimal protective immune responses","volume":"9","author":"Saeidi","year":"2018","journal-title":"Front Immunol"},{"key":"2021101018332647100_keab345-B24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"2021101018332647100_keab345-B25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fcimb.2012.00122","article-title":"Toll-like receptor sensing of human herpesvirus infection","volume":"2","author":"West","year":"2012","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab345\/38624720\/keab345.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/SI\/SI90\/40544626\/keab345.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/60\/SI\/SI90\/40544626\/keab345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T02:49:20Z","timestamp":1633920560000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/60\/SI\/SI90\/6225015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,13]]},"references-count":25,"journal-issue":{"issue":"SI","published-online":{"date-parts":[[2021,4,13]]},"published-print":{"date-parts":[[2021,10,9]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab345","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,4,13]]}}}